Re: ZEN-3694 Single Agent Trial Status

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZEN-3694 Single Agent Trial Status

in response to

ZEN-3694 Single Agent Trial Status

BearDownAZ

posted on Jul 14, 2017 02:24PM

Does anyone have any reason why we have no news releases on the current trial ZEN 3694, I thought this trial would be very quick and we would have some new either way

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply